Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Retatrutide (LY3437943) is an investigational compound that has not been approved by the FDA as of April 2026
Allergic reactions to tirzepatide are distinct from bruising and present with hives, itching, swelling of the face or throat, or difficulty breathing
GLP-1 receptor agonists bind to GLP-1 receptors expressed throughout the body, including pancreatic beta cells, the central nervous system, cardiovascular tissue, and adipose tissue
Half-life refers to biological activity duration in the bodynot chemical stability in storage
Choose tirzepatide for maximum weight loss or semaglutide for best value
Other compounds in this field include epitalon and thymalin
US$ 20.52
US$ 26.07
US$ 29.40
US$ 27.85
